Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Neoplasms

Explore clinical trials studying Fallopian Tube Neoplasms. Study availability and eligibility vary by location and protocol.

600 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Neoplasms trial results

Completed

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

NCT01478685

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +49 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 13 locations
View Trial Details
Completed

Study of Ramucirumab in Ovarian Cancer

NCT00721162

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • ImClone Investigational Site Hollywood, Florida, United States
  • ImClone Investigational Site Orlando, Florida, United States
  • ImClone Investigational Site Chicago, Illinois, United States
  • ImClone Investigational Site Marrero, Louisiana, United States
View all 13 locations
View Trial Details
Completed

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

NCT01666444

Conditions
Adnexal Diseases, Brenner Tumor, Carcinoma, +26 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Winthrop P. Rockefeller Cancer Institute - University of Arkansas Little Rock, Arkansas, United States
  • Providence Saint Joseph Medical Center Burbank, California, United States
  • Kaiser Permanente Medical Center Hayward, California, United States
View all 136 locations
View Trial Details
Completed

A Study LY2228820 for Recurrent Ovarian Cancer

NCT01663857

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • St Josephs Hospital and Medical Center Phoenix, Arizona, United States
  • Arizona Oncology Associates, P.C. Tucson, Arizona, United States
  • Sarasota Memorial Hospital Sarasota, Florida, United States
  • H Lee Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details
Completed

Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01504126

Conditions
Adnexal Diseases, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Diseases, +44 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Lyndon Baines Johnson General Hospital Houston, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • The Woman's Hospital of Texas Houston, Texas, United States
View Trial Details
Completed

Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01074411

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +41 more
Locations
  • Hartford Hospital Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 14 locations
View Trial Details

Related conditions